Posts Tagged 'heart attack'

Myocardial infarction risk elevated by testosterone therapy

A story in Cardiology Today reports that some men taking testosterone therapy show an increased risk in myocardial infarction. Data shows an elevated risk in groups of older and younger men with a previous history of cardiovascular disease. This information, along with other studies prompted the FDA’s decision to review the dangers associated with testosterone therapy.

Myocardial infarction, stroke, and death were increased in the population of men taking testosterone therapy. The recent study analyzed the risk ...

continue reading...

Testosterone therapy shown to be uneccessary in many cases

A recent story in the Washington Post describes a report by the Endocrine Society that many men are receiving testosterone therapy when they do not need it.  The research demonstrates that a large portion of patients do not meet the accepted clinical criteria for receiving testosterone treatment.

The male sex hormone, testosterone, naturally declines with age. Hypogonadism is a condition that results from low testosterone and one that is generally treated with therapy. However, many men are ...

continue reading...

FDA issues stricter warning for epilepsy drug Gilenya

The U.S. Food and Drug Administration has reviewed Novartis AG’s multiple sclerosis drug Gilenya, and concluded that patients who’ve suffered a heart attack or stroke within the past six months shouldn’t take it.

The review came about after a 59-year-old patient died in November, less than 24 hours after taking the first dose of the drug.

Europe’s drug regulator, the European Medicines Agency, recently requested stronger safety warnings for Gilenya after the agency concluded its review of the drug.

According to Dow Jones ...

continue reading...
Page 2 of 2 12